Shares of HemaCare Co. (OTCMKTS:HEMA – Get Free Report) traded up 0.6% on Thursday . The stock traded as high as $25.31 and last traded at $25.31. 5,400 shares changed hands during mid-day trading, a decline of 86% from the average session volume of 39,950 shares. The stock had previously closed at $25.16.
HemaCare Trading Up 0.6 %
The company has a fifty day moving average price of $25.31 and a 200-day moving average price of $25.31.
HemaCare Company Profile
HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy.
Read More
- Five stocks we like better than HemaCare
- Trading Halts Explained
- MarketBeat Week in Review – 4/22 – 4/26
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- 3 Stocks Leading the U.S. Agriculture Comeback
- Stock Market Sectors: What Are They and How Many Are There?
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for HemaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HemaCare and related companies with MarketBeat.com's FREE daily email newsletter.
